Status:
COMPLETED
Manualized Group Cognitive-behavioral Therapy for Social Anxiety in First Episode Psychosis
Lead Sponsor:
Douglas Mental Health University Institute
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Social Phobia
Psychosis
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Social anxiety represents one of the most prevalent comorbid conditions in schizophrenia and related psychosis. Schizophrenia patients with comorbid social anxiety often exhibit impaired social functi...
Detailed Description
Preamble Social anxiety is highly prevalent in people with schizophrenia and related psychotic disorders, and represents a major obstacle to a positive functional outcome. The investigators have rece...
Eligibility Criteria
Inclusion
- diagnosis of a psychotic disorder (as determined by the SCID and consensus meeting between two research psychiatrists);
- ability to read and write English or French at an intermediate level (Education \> 8 years);
- social anxiety scores above predetermined cut-offs on at least one of the three social anxiety measures (34 for the SIAS, above 19 for the SPIN and above 20 for the BSPS); and the presence of observable clinical symptoms supporting the diagnosis of a social anxiety disorder on Axis I and determined with the SCID social phobia module.
Exclusion
- currently clinically unstable, defined as the presence of positive symptoms that are moderate to severe on the SAPS rating scale;
- IQ\<70;
- currently hospitalized or hospitalized at the time of recruitment;
- a change in medication within the past 6 weeks; presence of a current episode of major depression (evidenced by Calgary Depression Scale (CDS) rating score of 8 or greater);
- current diagnosis of substance dependence (but a diagnosis of substance abuse is not an exclusion criterion);
- lifetime history of a neurological condition;
- history of mental retardation or autism spectrum disorders.
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 19 2019
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT02294409
Start Date
October 1 2014
End Date
December 19 2019
Last Update
October 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Douglas Mental Health University Institute
Verdun, Quebec, Canada, H4H 1R3